Table 2.
Total | Men | Women | |
---|---|---|---|
AUC(95% CI) | AUC(95%CI) | AUC(95%CI) | |
Lipid measures | |||
TC | 0.543 (0.498–0.589) | 0.537 (0.481–0.592) | 0.562 (0.482–0.642) |
TG | 0.525 (0.480–0.570) | 0.499 (0.444–0.554) | 0.576 (0.500–0.652) |
HDL-C | 0.462 (0.417–0.507) | 0.480 (0.426–0.535) | 0.435 (0.356–0.514) |
LDL-C | 0.555 (0.510–0.601) | 0.547 (0.491–0.603) | 0.573 (0.493–0.653) |
Non-HDL-C | 0.559 (0.513–0.604) | 0.543 (0.488–0.599) | 0.590 (0.511–0.669) |
RC | 0.538 (0.493–0.583) | 0.529 (0.475–0.584) | 0.558 (0.481–0.635) |
Apo A-I | 0.456 (0.411–0.501) | 0.465 (0.410–0.520) | 0.424 (0.345–0.504) |
Apo B | 0.576 (0.531–0.622) | 0.561 (0.505–0.617) | 0.605 (0.527–0.683) |
Lipid ratios | |||
TC/HDL-C | 0.566 (0.521–0.611) | 0.546 (0.491–0.601) * | 0.608 (0.531–0.684) |
TG/HDL-C | 0.535 (0.490–0.579) * | 0.511 (0.456–0.566) * | 0.580 (0.503–0.657) |
LDL-C/HDL-C | 0.570 (0.525–0.615) | 0.555 (0.499–0.611) | 0.603 (0.526–0.680) |
RC/HDL-C | 0.544 (0.500–0.589) | 0.530 (0.475–0.584) | 0.575 (0.498–0.652) |
Non- HDL-C/HDL-C | 0.566 (0.521–0.611) | 0.546 (0.491–0.601) * | 0.608 (0.531–0.684) |
Apo B/ HDL-C | 0.578 (0.533–0.623) | 0.562 (0.506–0.617) | 0.617 (0.541–0.693) |
Apo B/apo A-I | 0.588 (0.543–0.633) | 0.579 (0.523–0.634) | 0.613 (0.536–0.690) |
TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, RC remnant cholesterol, Non-HDL-C non-high-density lipoprotein cholesterol, Apo B apolipoprotein B, Apo A-I apolipoprotein A-I, AUC area under the curve; 95%CI 95% confidence interval, ICAS intracranial atherosclerotic stenosis. * P < 0.05, AUC were compared with apo B/apo A-I ratio in lipid ratios